Record #51367

The role of second generation sequencing technology and nanomedicine in the monitoring and treatment of lower extremity deep vein thrombosis susceptibility genes

Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
1
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~0.4 citations/yr after
citing papers

Who is still citing this work

Loading…